La Jolla Pharmaceutical Company
LJPC
LJPC was delisted on the 19th of August, 2022.
35 hedge funds and large institutions have $176M invested in La Jolla Pharmaceutical Company in 2014 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.
322% more call options, than puts
Call options by funds: $333K | Put options by funds: $79K
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
160% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 5
145% more capital invested
Capital invested by funds: $72.1M → $176M (+$104M)
21% more funds holding
Funds holding: 29 → 35 (+6)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTC
Ghost Tree Capital
New York
|
+$3.4M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$2.76M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$2.31M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$1.14M |
| 5 |
D.E. Shaw & Co
New York
|
+$782K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IHM
Iguana Healthcare Management
New York
|
-$1.73M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.46M |
| 3 |
SIM
SSI Investment Management
Los Angeles,
California
|
-$469K |
| 4 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
-$318K |
| 5 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
-$304K |
LJPC Hedge Fund Activity: Q4 2014 in Review
35 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q4 2014, worth a combined $176M — up 145% from $72.1M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new LJPC positions and 5 closed out — a net gain of 8 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $3.4M. The largest seller was Iguana Healthcare Management, exiting entirely with an estimated $1.73M sold.
- 35 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q4 2014, up from 29 in Q3 2014.
- Funds reported $176M of La Jolla Pharmaceutical Company stock for Q4 2014, up 145% quarter-over-quarter.
- 13 funds opened new La Jolla Pharmaceutical Company positions in Q4 2014 and 5 closed out, a net change of +8 holders.
- The largest La Jolla Pharmaceutical Company buyer in Q4 2014 was Ghost Tree Capital, an estimated $3.4M added.
- The largest La Jolla Pharmaceutical Company seller in Q4 2014 was Iguana Healthcare Management, an estimated $1.73M sold.
Based on aggregated 13F filings for Q4 2014.